HDAC9 and cystic fibrosis: These findings were confirmed by a study by Bodas et al. and they extended the work to examine the pan HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) in a CF mouse model where inflammation was stimulated by Pseudomonas aeruginosa lipopolysaccharide (Pa-LPS) exposure11.